What does VANDERVEKEN MEDICAL COMMUNICATION do?

VANDERVEKEN MEDICAL COMMUNICATION is an events organiser in Jodoigne. Private Limited, started on 10 January 2001, 1 establishment.

What is the address of VANDERVEKEN MEDICAL COMMUNICATION?

The registered office of VANDERVEKEN MEDICAL COMMUNICATION is located at Rue de la Vinaudrée(J.-S.) 30, 1370 Jodoigne.

Is VANDERVEKEN MEDICAL COMMUNICATION still active?

Yes. According to the CBE (17 September 2026) VANDERVEKEN MEDICAL COMMUNICATION is active, legal situation “Normale toestand”, started on 10 January 2001.

Is VANDERVEKEN MEDICAL COMMUNICATION registered on Peppol?

Yes, VANDERVEKEN MEDICAL COMMUNICATION is registered on the Peppol network with ID 0208:0473768289.

What is the enterprise number of VANDERVEKEN MEDICAL COMMUNICATION?

The enterprise number of VANDERVEKEN MEDICAL COMMUNICATION is BE0473768289.

When was VANDERVEKEN MEDICAL COMMUNICATION founded?

VANDERVEKEN MEDICAL COMMUNICATION was founded on 10 January 2001.

Who are the directors of VANDERVEKEN MEDICAL COMMUNICATION?

According to the 2025 annual accounts, the directors of VANDERVEKEN MEDICAL COMMUNICATION are: MURIEL VANDERVEKEN.

Is VANDERVEKEN MEDICAL COMMUNICATION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 January 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did VANDERVEKEN MEDICAL COMMUNICATION make in 2025?

VANDERVEKEN MEDICAL COMMUNICATION posted a profit after taxes of € 15,715 in financial year 2025.

What is the revenue of VANDERVEKEN MEDICAL COMMUNICATION?

In its most recent annual accounts (2025), VANDERVEKEN MEDICAL COMMUNICATION reported revenue of € 76,170.

VANDERVEKEN MEDICAL COMMUNICATION (Private Limited)

Dossier VANDERVEKEN MEDICAL COMMUNICATION, printed on 17 September 2026 from databakkes.be/en/0473768289/vanderveken-medical-communication. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VANDERVEKEN MEDICAL COMMUNICATION from Jodoigne, company number BE0473768289, closed financial year 2025 with a result of € 15,715 after tax. For that financial year VANDERVEKEN MEDICAL COMMUNICATION recorded revenue of € 76,170 and equity of € 91,401. Compared with financial year 2024, the result moved from € 20,404 to € 15,715. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Growing

€ 91,401

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 15,715

▼ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 36,738

▲ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 85,201.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,520

▲ € 1,386 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,500

▼ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 33,437 Revenue 2022: € 33,437 First fiscal year in the series	€ 70,435 Revenue 2023: € 70,435 ▲ 111% vs 2022 (€ 33,437) Favourable step	€ 83,841 Revenue 2024: € 83,841 ▲ 19% vs 2023 (€ 70,435) Favourable step	€ 76,170 Revenue 2025: € 76,170 ▼ 9% vs 2024 (€ 83,841) Unfavourable step	▼ 9%
Gross margin	€ -3,269 Gross margin 2022: € -3,269 First fiscal year in the series	€ 17,952 Gross margin 2023: € 17,952 ▲ € 21,221 vs 2022 (€ -3,269) Favourable step	€ 29,942 Gross margin 2024: € 29,942 ▲ 67% vs 2023 (€ 17,952) Favourable step	€ 22,825 Gross margin 2025: € 22,825 ▼ 24% vs 2024 (€ 29,942) Unfavourable step	▼ 24%
Profit after taxes	€ -4,305 Profit after taxes 2022: € -4,305 First fiscal year in the series	€ 11,283 Profit after taxes 2023: € 11,283 ▲ € 15,588 vs 2022 (€ -4,305) Favourable step	€ 20,404 Profit after taxes 2024: € 20,404 ▲ 81% vs 2023 (€ 11,283) Favourable step	€ 15,715 Profit after taxes 2025: € 15,715 ▼ 23% vs 2024 (€ 20,404) Unfavourable step	▼ 23%
Equity	€ 43,999 Equity 2022: € 43,999 First fiscal year in the series	€ 55,281 Equity 2023: € 55,281 ▲ 26% vs 2022 (€ 43,999) Favourable step	€ 75,686 Equity 2024: € 75,686 ▲ 37% vs 2023 (€ 55,281) Favourable step	€ 91,401 Equity 2025: € 91,401 ▲ 21% vs 2024 (€ 75,686) Favourable step	▲ 21%
Total debts	€ 465 Total debts 2022: € 465 First fiscal year in the series	€ 2,804 Total debts 2023: € 2,804 ▲ € 2,339 vs 2022 (€ 465) Unfavourable step	€ 3,960 Total debts 2024: € 3,960 ▲ 41% vs 2023 (€ 2,804) Unfavourable step	€ 3,020 Total debts 2025: € 3,020 ▼ 24% vs 2024 (€ 3,960) Favourable step	▼ 24%
Cash	€ 37,826 Cash 2022: € 37,826 First fiscal year in the series	€ 52,503 Cash 2023: € 52,503 ▲ 39% vs 2022 (€ 37,826) Favourable step	€ 26,857 Cash 2024: € 26,857 ▼ 49% vs 2023 (€ 52,503) Unfavourable step	€ 36,738 Cash 2025: € 36,738 ▲ 37% vs 2024 (€ 26,857) Favourable step	▲ 37%
Retained profit	€ 37,799 Retained profit 2022: € 37,799 First fiscal year in the series	€ 49,081 Retained profit 2023: € 49,081 ▲ 30% vs 2022 (€ 37,799) Favourable step	€ 69,486 Retained profit 2024: € 69,486 ▲ 42% vs 2023 (€ 49,081) Favourable step	€ 85,201 Retained profit 2025: € 85,201 ▲ 23% vs 2024 (€ 69,486) Favourable step	▲ 23%
Balance sheet total	€ 44,464 Balance sheet total 2022: € 44,464 First fiscal year in the series	€ 58,086 Balance sheet total 2023: € 58,086 ▲ 31% vs 2022 (€ 44,464) Unchanged	€ 79,645 Balance sheet total 2024: € 79,645 ▲ 37% vs 2023 (€ 58,086) Unchanged	€ 94,421 Balance sheet total 2025: € 94,421 ▲ 19% vs 2024 (€ 79,645) Unchanged	▲ 19%

Key figures of VANDERVEKEN MEDICAL COMMUNICATION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VANDERVEKEN MEDICAL COMMUNICATION?

What happened at VANDERVEKEN MEDICAL COMMUNICATION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 15,715 (▼ 23% vs 2024). Source: NBB ↗
Feb 15, 2001 New establishment in Jodoigne. KBO
Jan 10, 2001 Start of the company according to the CBE. KBO

In short

From € 4,305 loss in 2022 to € 15,715 profit in 2025.

Paid € 20,872 in corporate taxes since 2022.

Best year ever: 2024, with € 20,404 profit.

Original PDFs at the National Bank ↗

A new publication or filing at VANDERVEKEN MEDICAL COMMUNICATION? We notify you, reason included.

Follow VANDERVEKEN MEDICAL COMMUNICATION

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MURIEL VANDERVEKEN

VANDERVEKEN MEDICAL COMMUNICATION

Behind VANDERVEKEN MEDICAL COMMUNICATION is MURIEL VANDERVEKEN.

See the full network in the app

Directors

According to the 2025 annual accounts

MURIEL VANDERVEKEN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Vinaudrée(J.-S.) 30

1370 Jodoigne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0473.768.289

VAT number

BE 0473.768.289

Registered office

Rue de la Vinaudrée(J.-S.) 30, 1370 Jodoigne

Names & denominations

VANDERVEKEN MEDICAL COMMUNICATION · VANDEMECOM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 January 2001

Peppol

Active · Active since 4 Dec 2025

Activities · NACE

Organisatie van congressen en beurzen

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige vormen van onderwijs

Overige zakelijke dienstverlening, neg

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗